Good point. You would think only a matter of time until the market catches wind. A biotech company with revenue scale, an actual commercial presence in the holy grail of the US, and with profitability forecast within the next 3-5 years. This is the same market that values IMU at 2.7b (not diluted) without a single cent of product sold.
PEB Price at posting:
0.0¢ Sentiment: Buy Disclosure: Held
